36 research outputs found
Synthesis and reactivity of cobalt complexes derived from tris(2-pyridylthio)methane ligand: Structural characterization of cobalt(III) complexes containing cobaltâcarbon bond
1394-1402The synthesis, characterization and reactivity of a cobalt(II) complex,
[(HL1)CoII(PyS)](ClO4) (1) (where
HL1 = tris(2-pyridylthio)methane and PyS = monoanionic
pyridine-2-thiolate) are discussed. Complex (1) reacts with molecular oxygen to yield a mononuclear low-spin
cobalt(III) complex, [(L1)CoIII(PyS)](ClO4) (2). On the other hand, treatment of (1) with a protic acid (pyridinium
perchlorate) followed by a base (triethylamine) and dioxygen
forms an isomeric cobalt(III) complex, [(L2)CoIII(PyS)](ClO4)
(3) (L2 =
1-[bis(2-pyridylthio)methyl]pyridine-2-thione). Ligand HL1 (in 1)
rearranges to L2 (in 3)
during the reaction as a result of CâS bond cleavage and subsequent CâN bond
formation. X-ray crystal structures of both (2) and (3) reveal a
distorted octahedral coordination geometry at cobalt(III) center with a strong
cobaltâcarbon bonding interaction. A four-coordinate distorted tetrahedral
cobalt(II) complex, [CoII(PySH)4](ClO4)2
(4) is formed via CâS bond cleavage
of HL1 in the reaction of (1)
with an excess amount of pyridinium perchlorate. The electronic structure of (2) as established by DFT calculation
suggests a delocalized LUMO with significant contribution from the metal ion.
The organocobalt(III) complex converts to an air-stable organocobalt(II)
complex (2red) upon
one-electron reduction
Oxygenation of Organoboronic Acids by a Nonheme Iron(II) Complex: Mimicking Boronic Acid Monooxygenase Activity
Phenolic compounds
are important intermediates in the bacterial biodegradation of aromatic
compounds in the soil. An <i>Arthrobacter sp.</i> strain
has been shown to exhibit boronic acid monooxygenase activity through
the conversion of different substituted phenylboronic acids to the
corresponding phenols using dioxygen. While a number of methods have
been reported to cleave the CâB bonds of organoboronic acids,
there is no report on biomimetic iron complex exhibiting this activity
using dioxygen as the oxidant. In that direction, we have investigated
the reactivity of a nucleophilic ironâoxygen oxidant, generated
upon oxidative decarboxylation of an ironÂ(II)âbenzilate complex
[(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(benzilate)] (Tp<sup>Ph2</sup> =
hydrotrisÂ(3,5-diphenyl-pyrazol-1-yl)Âborate), toward organoboronic
acids. The oxidant converts different aryl/alkylboronic acids to the
corresponding oxygenated products with the incorporation of one oxygen
atom from dioxygen. This method represents an efficient protocol for
the oxygenation of boronic acids with dioxygen as the terminal oxidant
Oxygenative Aromatic Ring Cleavage of 2âAminophenol with Dioxygen Catalyzed by a Nonheme Iron Complex: Catalytic Functional Model of 2âAminophenol Dioxygenases
2-Aminophenol dioxygenases catalyze
the oxidative ring cleavage
of 2-aminophenol to 2-picolinic acid using O<sub>2</sub> as the oxidant.
Inspired by the reaction catalyzed by these nonheme iron enzymes,
a biomimetic ironÂ(III)-2-amidophenolate complex, [(<i>t</i>Bu-L<sup>Me</sup>)ÂFe<sup>III</sup>(4,6-di-<i>t</i>Bu-AP)]Â(ClO<sub>4</sub>) (<b>1a</b>) of a facial tridentate ligand (<i>t</i>Bu-L<sup>Me</sup> = 1-[bisÂ(6-methyl-pyridin-2-yl)-methyl]-3-<i>tert</i>-butyl-urea and 4,6-di-<i>t</i>Bu-H<sub>2</sub>AP = 2-amino-4,6-di-<i>tert</i>-butylphenol) bearing a
urea group have been isolated. The complex reacts with O<sub>2</sub> to cleave the CâC bond of 4,6-di-<i>t</i>Bu-AP
regioselectively and catalytically to afford 4,6-di-<i>tert</i>-butyl-2-picolinic acid. An ironÂ(II)-chloro complex [(<i>t</i>Bu-L<sup>Me</sup>)ÂFe<sup>II</sup>Cl<sub>2</sub>(MeOH)] (<b>1</b>) of the same ligand also cleaves the aromatic ring of 4,6-di-<i>t</i>Bu-AP catalytically in the reaction with O<sub>2</sub>.
To assess the effect of urea group on the ring cleavage reaction of
2-aminophenol, two iron complexes, [(BA-L<sup>Me</sup>)<sub>2</sub>Fe<sup>II</sup><sub>2</sub>Cl<sub>4</sub>] (<b>2</b>) and [(BA-L<sup>Me</sup>)ÂFe<sup>III</sup>(4,6-di-<i>t</i>Bu-AP)]Â(ClO<sub>4</sub>) (<b>2a</b>), of a tridentate ligand devoid of urea
group (BA-L<sup>Me</sup> = benzyl-[bisÂ(6-methyl-pyridin-2-yl)-methyl]-amine)
have been isolated and characterized. Although the iron complexes
(<b>1</b> and <b>1a</b>) of the ligand with urea group
display catalytic reaction, the iron complexes (<b>2</b> and <b>2a</b>) of the ligand without urea group do not exhibit catalytic
aromatic ring fission reactivity. The results support the role of
urea group in directing the catalytic reactivity exhibited by <b>1</b> and <b>1a</b>
Iron(II)-catecholate complexes of a monoanionic facial <i style="">N<sub>3</sub></i> ligand: Structural and functional models of the extradiol cleaving catechol dioxygenases
420-426Two biomimetic iron(II)-catecholate
complexes, [(TpPh2)FeII(CatH)] (1) and [(TpPh2)FeII(DBCH)]
(2) (where TpPh2 = hydrotris(3,5-diphenylpyrazole-1-yl)borate,
CatH = monoanionic pyrocatecholate and DBCH = monoanionic 3,5-di-tert-butyl catecholate), have been isolated and characterized to
study their reactivity towards dioxygen. The single-crystal X-ray structure of (1) reveals a high-spin iron(II) center
ligated by the monoanionic facial N3
ligand and a monoanionic catecholate, giving rise to a trigonal bipyramidal
coordination geometry. Complex (1) represents the first structurally characterized five-coordinate
iron(II)-catecholate complex with an asymmetric bidentate binding motif of
monoanionic catecholate. While (1)
reacts with dioxygen to form the corresponding iron(III)-catecholate, (2) reacts with dioxygen to give 75 %
extradiol and 25 % intradiol cleavage products via an iron(III)-catecholate
intermediate species. Complex (2) is
a potential functional model of extradiol cleaving catechol dioxygenases
The methanol-methanolate CH3OH···CH3- bridging ligand: Tuning of exchange coupling by hydrogen bonds in dimethoxo-bridged dichromium(III) complexes
Two bis(mu-methoxo)dichromium(III) complexes, [(L2Cr2)-Cr- Se(mu-OCH3)(2)(CH3OH)(2)] 1 and [(L2Cr2)-Cr-Se(mu- OCH3)(2)(CH3OH)(CH3O)](-) 2, where L-Se represents the dianion of 2,2'-selenobis(4,6-di-tertbutylphenol), have been reported to demonstrate the effect of hydrogen bonding on the exchange coupling interactions between the chromium(Ill) centers. The corresponding sulfur analogue of the ligand, i.e., 2,2'- thiobis(4,6-di-tert-butylphenol), also yields the analogous [(L2Cr2)-Cr-S(Umu-OCH3)(2)(CH3OH)(2)] 3 and [(L2Cr2)-Cr-S(mu- OCH3)(2)(CH3O)(CH3OH)](-) 4, which exhibit similar exchange coupling parameters. An acid-base dependent equilibrium between I and 2 or 3 and 4 has been established by electronic spectral measurements
Reactivity of an IronâOxygen Oxidant Generated upon Oxidative Decarboxylation of Biomimetic Iron(II) αâHydroxy Acid Complexes
Three biomimetic ironÂ(II) α-hydroxy
acid complexes, [(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(mandelate)Â(H<sub>2</sub>O)] (<b>1</b>), [(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(benzilate)]
(<b>2</b>), and [(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(HMP)] (<b>3</b>), together with two ironÂ(II) α-methoxy acid complexes,
[(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(MPA)] (<b>4</b>) and [(Tp<sup>Ph2</sup>)ÂFe<sup>II</sup>(MMP)] (<b>5</b>) (where HMP = 2-hydroxy-2-methylpropanoate,
MPA = 2-methoxy-2-phenylacetate, and MMP = 2-methoxy-2-methylpropanoate),
of a facial tridentate ligand Tp<sup>Ph2</sup> [where Tp<sup>Ph2</sup> = hydrotrisÂ(3,5-diphenylpyrazole-1-yl)Âborate] were isolated and
characterized to study the mechanism of dioxygen activation at the
ironÂ(II) centers. Single-crystal X-ray structural analyses of <b>1</b>, <b>2</b>, and <b>5</b> were performed to assess
the binding mode of an α-hydroxy/methoxy acid anion to the ironÂ(II)
center. While the ironÂ(II) α-methoxy acid complexes are unreactive
toward dioxygen, the ironÂ(II) α-hydroxy acid complexes undergo
oxidative decarboxylation, implying the importance of the hydroxyl
group in the activation of dioxygen. In the reaction with dioxygen,
the ironÂ(II) α-hydroxy acid complexes form ironÂ(III) phenolate
complexes of a modified ligand (Tp<sup>Ph2</sup>*), where the ortho
position of one of the phenyl rings of Tp<sup>Ph2</sup> gets hydroxylated.
The ironÂ(II) mandelate complex (<b>1</b>), upon decarboxylation
of mandelate, affords a mixture of benzaldehyde (67%), benzoic acid
(20%), and benzyl alcohol (10%). On the other hand, complexes <b>2</b> and <b>3</b> react with dioxygen to form benzophenone
and acetone, respectively. The intramolecular ligand hydroxylation
gets inhibited in the presence of external intercepting agents. Reactions
of <b>1</b> and <b>2</b> with dioxygen in the presence
of an excess amount of alkenes result in the formation of the corresponding <i>cis</i>-diols in good yield. The incorporation of both oxygen
atoms of dioxygen into the diol products is confirmed by <sup>18</sup>O-labeling studies. On the basis of reactivity and mechanistic studies,
the generation of a nucleophilic ironâoxygen intermediate upon
decarboxylation of the coordinated α-hydroxy acids is proposed
as the active oxidant. The novel ironâoxygen intermediate oxidizes
various substrates like sulfide, fluorene, toluene, ethylbenzene,
and benzaldehyde. The oxidant oxidizes benzaldehyde to benzoic acid
and also participates in the Cannizzaro reaction